Cargando…
Correction: Overall survival of stage IV non-small cell lung cancer patients treated with Viscum album L. in addition to chemotherapy, a real-world observational multicenter analysis
Autores principales: | Schad, Friedemann, Thronicke, Anja, Steele, Megan L., Merkle, Antje, Matthes, Burkhard, Grah, Christian, Matthes, Harald |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9380908/ https://www.ncbi.nlm.nih.gov/pubmed/35972953 http://dx.doi.org/10.1371/journal.pone.0273387 |
Ejemplares similares
-
Overall survival of stage IV non-small cell lung cancer patients treated with Viscum album L. in addition to chemotherapy, a real-world observational multicenter analysis
por: Schad, Friedemann, et al.
Publicado: (2018) -
Overall Survival of Nonmetastasized NSCLC Patients Treated With Add-On Viscum album L: A Multicenter Real-World Study
por: Thronicke, Anja, et al.
Publicado: (2020) -
Cost-effectiveness of real-world administration of chemotherapy and add-on Viscum album L. therapy compared to chemotherapy in the treatment of stage IV NSCLC patients
por: Thronicke, Anja, et al.
Publicado: (2020) -
Clinical Safety of Combined Targeted and Viscum album L. Therapy in Oncological Patients
por: Thronicke, Anja, et al.
Publicado: (2018) -
Clinical safety of combined therapy of immune checkpoint inhibitors and Viscum album L. therapy in patients with advanced or metastatic cancer
por: Thronicke, Anja, et al.
Publicado: (2017)